Global Clinical Biomarker Testing Market Size, Status and Forecast 2021-2027

Global Clinical Biomarker Testing Market Size, Status and Forecast 2021-2027

  • QYResearch
  • April 2021
  • Healthcare
  • 108 pages

Report Description

Global Clinical Biomarker Testing Scope and Market Size
Clinical Biomarker Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Clinical Biomarker Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Cancer
Metabolism
Infectious Disease
Cardiology
Neurology
Immunological Disease

Segment by Application
Drug Discovery
Nutrigenomics
Toxicology Testing
Personalized Medicine
Functional Genomics

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
AbbVie Inc.
Adaptive Biotechnologies
Agilent Technologies
BD
Becton Dickinson
Bio-Rad Laboratories
Danaher Corporation
Merck and Co.
Thermofisher Scientific

Have query on this report?

Make an Enquiry
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Biomarker Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cancer
List of Tables
Table 1. Global Clinical Biomarker Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cancer
Table 3. Key Players of Metabolism
Table 4. Key Players of Infectious Disease
Table 5. Key Players of Cardiology

Success Stories

Our Clients